New Executive Order Creates NIH Women's Health Division and Task Force

For decades, conditions that largely affect women, such as endometriosis and menopause, have not been researched in proportion to their impact. On Monday, President Donald Trump signed an executive order meant to change that, establishing a new Women's Health Division at the National Institutes of Health and a White House task force to coordinate the effort.

First lady Melania Trump was the driving force behind the initiative, working with federal health officials to shape it. "Beginning today we will change the reality of women's health," she told the audience at the Rose Garden ceremony. In Silicon Valley, where a growing number of startups are developing diagnostics, apps and AI tools for women's health, the real interest lies in what the order actually funds and how quickly it can turn research into care.

What the Order Does

The order, titled Advancing Women's Health to Improve Outcomes in All Phases of Life, directs the Department of Health and Human Services to set up a Women's Health Division within the NIH within 90 days. The division is meant to coordinate federally funded research, fill gaps in scientific knowledge and speed the path from findings to better clinical care, working alongside the NIH's existing Office of Research on Women's Health, which dates to 1990.

It also creates the first White House Women's Health Task Force, co-chaired by HHS Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles. The administration describes a lifespan approach that covers health from infancy and adolescence through pregnancy, midlife, menopause and aging.

The research priorities named in the order and its accompanying fact sheet are broad: cardiovascular disease, cancer, stroke, Alzheimer's disease, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, infertility, maternal health, menopause and neurological disorders. Trump said the order would "promote new research and really go after the understudied diseases affecting women."

What Health Officials Say

Federal health officials presented the move as a correction long in coming. "For generations, women have faced unanswered questions about conditions that uniquely or disproportionately affect them," Kennedy said in the HHS announcement. NIH Director Jay Bhattacharya said the new division "will help close lingering evidence gaps" and bring discoveries closer to patients, and CDC Director Erica Schwartz said the order "will help us put proven interventions into practice."

Melania Trump, whose second-term work has centered on children, foster care and technology in education, put the stakes in generational terms. "Our generation will fight to discover the cures that will ensure a woman can live her life in health and to the fullest," she said.

How It Differs From the Last Effort

The White House is not new to the issue. In 2023, the Biden administration issued its own executive order on women's health research, led by then first lady Jill Biden, which the Bidens said attracted nearly $1 billion in federal funding from agencies including the NIH and the Defense Department. Trump's order rescinds that earlier initiative.

The White House says its approach goes further: it creates a government-wide task force rather than a first lady-led effort, it focuses on moving research into clinical practice, and it plans to use artificial intelligence. The fact sheet also points to related steps, including the FDA's move last year to remove broad black box warnings from menopause hormone therapy products and new federal resources for expecting and new mothers.

The Questions Hanging Over It

The order sets no specific funding goals, and the administration has not said who will lead the new division or how large its budget will be. That is of real consequence, since the same administration has made broad cuts to federal science funding, including studies focused on women, and has kept eliminating grants with a diversity focus. Last year it also announced that the long-running Women's Health Initiative study would be wound down early, then reversed course after protests.

The timing has not gone unnoticed either. The order arrives about two weeks before the Nov. 3 elections, at a moment when health care ranks among the top concerns of women voters. Supporters say the substance counts more than the calendar; skeptics are waiting to see whether money follows the announcement.

Why It Matters for Health Startups

In digital health, women's health has become a busy corner, with companies working on fertility tracking, menopause care, pelvic health, pregnancy monitoring and at-home testing. For those companies, federal research priorities shape far more than headlines. They influence what clinical evidence exists, which conditions have validated diagnostic criteria and, ultimately, what doctors recommend and insurers are willing to cover.

A coordinated NIH effort could also produce larger, better organized data sets on conditions that have been studied in small pieces. Startups building AI models for symptom tracking or early detection depend on that kind of evidence to prove their tools work. The order's emphasis on moving research into clinical care could also open new partnerships between federal researchers, academic medical centers and private companies, including in the Bay Area's dense network of hospitals and health tech firms. For founders, a clearer map of federal priorities can also help decide which problems to tackle first and which clinical partners to approach.

Can a Government Order Speed Up Women's Health Innovation?

The possibilities are real. With an NIH division coordinating research, scientists, hospitals and companies could more easily see where the gaps are and apply for grants aimed at them. Millions of women live with conditions such as endometriosis, fibroids and difficult menopause symptoms, yet these have long been treated as niche; more federal attention could yield better information on how diseases, drugs and devices behave in women. That kind of data is the raw material Silicon Valley needs for better diagnostics, wearables and AI models, and a clear federal agenda might give investors more confidence to back women's health startups that have often struggled to raise money.

Then there are the very tangible concerns. Without dedicated funding, a new division risks being a reorganization rather than an expansion, and researchers who lost grants in recent cuts may stay skeptical until money actually flows. AI tools trained on incomplete or biased medical data could repeat the very gaps the order aims to close, and health data from apps and wearables raises privacy questions that federal rules have not fully answered. Research priorities that shift with each administration also make long-term studies hard to sustain. And because the task force is led by political appointees rather than career scientists, it is fair to ask whether priorities will be set by evidence or by politics.

The debate is partly political and partly practical. Supporters see a cause with bipartisan appeal getting high-level attention, along with a welcome emphasis on turning research into care. Critics argue that rescinding the previous initiative while cutting research budgets sends mixed signals, and that announcements matter less than appropriations. Few dispute that women's health research has been underfunded for a long time; the disagreement is over whether this order changes that.

The signals to watch are specific. Does the NIH stand up the division within 90 days, and who leads it? Do Congress or HHS attach real dollars to it? Do grants for endometriosis, menopause and maternal health increase in the next funding cycle? And will the planned AI work include safeguards for patient privacy and data quality?

Where Health Meets Silicon Valley

At Sparknify we have been watching how Silicon Valley handles the most personal side of health. We examined the ethical questions that arise when startups bring genetic testing and AI to fertility and family planning in Can We Give Our Children a Genetic Head Start? Silicon Valley Thinks So. A federal drive on women's health research could speed up that kind of innovation, but it also raises the stakes for getting the science, and the safeguards, right.

Few would argue against better research for women; the hard part is paying for it and following through.

Subscribe to Sparknify for Silicon Valley tech news and the people behind it.